1. Cancer Cells Become Susceptible to Natural Killer Cell Killing after Exposure to Histone Deacetylase Inhibitors Due to Glycogen Synthase Kinase-3–Dependent Expression of MHC Class I–Related Chain A and B
   Søren Skov et al, 2005, Cancer Research CrossRef
2. Evaluation of the Antitumor Efficacy, Pharmacokinetics, and Pharmacodynamics of the Histone Deacetylase Inhibitor Depsipeptide in Childhood Cancer Models In vivo
   Claire Graham et al, 2006, Clinical Cancer Research CrossRef
3. Histone Modification in NSCLC: Molecular Mechanisms and Therapeutic Targets
   Khuloud Bajbouj et al, 2021, International Journal of Molecular Sciences CrossRef